Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
James Joyce
AddedMar 31, 2024
UpdatedMay 31, 2026
James Joyce

James Joyce

Board Member, Sigyn Therapeutics

CrunchbaseLinkedIn

James Joyce's Career

Sigyn Therapeutics
Sigyn Therapeutics

San Diego, CA, US

Board Member· Board
Aethlon Medical
Aethlon Medical

San Diego, CA, US

Founder
Mission Labs
Mission Labs

San Francisco, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

James Joyce's Career

Sigyn Therapeutics
Sigyn Therapeutics
Public5San Diego, CA, US
Board Member· Board

Leadership at Sigyn Therapeutics

Craig RobertsCraig RobertsCo-Founder
Joseph SegelmanJoseph SegelmanBoard Member

Similar to Sigyn Therapeutics

SIGASIGANew York City, NY, USPharmaceuticalsest. 1995SIGANew York City, NY, US · est. 1995

SIGA Technologies: A US-based pharmaceutical firm specializing in oral antiviral drugs for smallpox treatment.

Public · $110.6M39
SpinogenixSpinogenixSan Diego, CA, USTherapeuticsest. 2016SpinogenixSan Diego, CA, US · est. 2016

Spinogenix: Developing transformative therapeutics for synaptic loss and dysfunction.

Pre-Seed · $11.6M8
Cygnal TherapeuticsCygnal TherapeuticsCambridge, MA, USDrugs, Pharmaceuticalsest. 2016Cygnal TherapeuticsCambridge, MA, US · est. 2016

US-based Cygnal Therapeutics develops exoneural drugs for cancer and regenerative diseases.

Series D · $65M37
SynedgenSynedgenClaremont, CA, USTherapeutics, Wound Healingest. 2009SynedgenClaremont, CA, US · est. 2009

US-based Synedgen Inc provides bio-pharmaceutical solutions for wound healing, tissue damage, and infections.

Seed · $15.9M35
Aethlon Medical
Aethlon Medical
Public$30.1M151999San Diego, CA, US
Founder

Leadership at Aethlon Medical

James FrakesJames FrakesBoard Member
Guy CiprianiGuy CiprianiBoard Member
Angela RossettiAngela RossettiBoard Member
Dr. Charles J. Fisher Jr.Dr. Charles J. Fisher Jr.Board Member
Edward BroennimanEdward BroennimanBoard Member
Dr Chetan S ShahDr Chetan S ShahBoard Member

Similar to Aethlon Medical

ExThera MedicalExThera MedicalMartinez, CA, USMedical Devicesest. 2008ExThera MedicalMartinez, CA, US · est. 2008

US-based ExThera Medical LLC specializes in commercial physical and biological R&D for medical devices.

Series A · $61.3M36
ExploraMed NC7ExploraMed NC7Mountain View, CA, USMedical Devicesest. 2014ExploraMed NC7Mountain View, CA, US · est. 2014

ExploraMed, a US-based medical tech incubator, accelerates the creation of innovative medical devices, meeting global health needs.

Series C · $132.6M30
Inari MedicalInari MedicalIrvine, CA, USMedical Devicesest. 2011Inari MedicalIrvine, CA, US · est. 2011

Inari Medical: A commercial-stage company developing devices to treat venous diseases.

Public · $44.1M1.1k
EmbolxEmbolxSunnyvale, CA, USMedical Devicesest. 2013EmbolxSunnyvale, CA, US · est. 2013

Embolx: A medical device startup innovating in cancer treatment with novel embolization microcatheters.

Seed · $2.5M12
Mission Labs
Mission Labs
Seed$100k82017San Francisco, CA, US
Co-Founder

Leadership at Mission Labs

Danny LaironDanny LaironCo-Founder
Jesse Soza, Ed.D.Jesse Soza, Ed.D.Co-Founder
Kat KalmykovKat KalmykovCo-Founder
Julian GuerreroJulian GuerreroCo-Founder
Kris WainscottKris WainscottCo-Founder
Brenden MulliganBrenden MulliganCo-Founder

Similar to Mission Labs

Team LabsTeam LabsSan Francisco, CA, USPlatform, Softwareest. 2012Team LabsSan Francisco, CA, US · est. 2012

Team Labs: Developing and installing intuitive products for smarter work and simpler creation.

Series A · $8M75
Untitled LabsUntitled LabsSan Francisco, CA, USConsumer Appsest. 2019Untitled LabsSan Francisco, CA, US · est. 2019

Untitled Labs: Innovating and building impactful tech products for large audiences.

Pre-Seed · $2.8M1
Operation LabsOperation LabsLa Cañada Flintridge, CA, USConsumer Productsest. 2019Operation LabsLa Cañada Flintridge, CA, US · est. 2019

California-based manufacturer and VC-backed tech lab, creating delightful mobile consumer products since 2019.

Seed · $185k5
Product LabProduct LabMiami, FL, USDigital Productsest. 2019Product LabMiami, FL, US · est. 2019

Product Lab is a Miami-based digital agency, transforming businesses with innovative tech solutions across various industries.

Seed · $100k34

James Joyce's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakBo ZhangBo ZhangCo-Founder · DiDiWILL WEI CHENGWILL WEI CHENGBoard Member · DiDi

People Similar to James Joyce

Jay JumperJay JumperFounder & CEO · PronvestAlexandra WeinerAlexandra WeinerFounder · SigmendAndy BindeaAndy BindeaFounder & CEO · SigoraJohn WilliamsJohn WilliamsBoard Member · BioSigniaHaisheng ZhangHaisheng ZhangFounder · Signet Therapeutics